Novavax, Inc. (NVV1.F) FSX

6.89

-0.561(-7.53%)

Updated at January 14 06:14PM

Currency In EUR

Valuation

Market Cap1.24B
Enterprise Value940.43M
P/E Ratio3.82
PEG Ratio-0.2
Price/Sales Ratio1.23
Price/Book Ratio-8.32
Enterprise/Revenue1.21
Enterprise/EBITDA3.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.32
Operating Margin0.29

Management Effectiveness

Return On Assets0.29
Return On Equity-1.67

Income Statement

Revenue682.16M
Revenue/Share6.56
Gross Profit479.42M
EBITDA-108.04M
Net Income-187.5M
Diluted EPS-1.23

Balance Sheet

Total Cash762.89M
Total Cash/Share4.7
Total Debt251.14M
Total Debt/Equity-1.6
Current Ratio2.27
Book Value Per Share-0.97

Price History

52-Week Change-16.57
52-Week High9.24
52-Week Low4.56
Moving Average 50 Days5.95
Moving Average 200 Days6.34

Statistics

Average Volume2,689.6
Shares Outstanding162.49M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMay 10, 2019